RT Journal Article
SR Electronic
T1 Characterization of direct and/or indirect genetic associations for multiple traits in longitudinal studies of disease progression
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.10.21256880
DO 10.1101/2021.05.10.21256880
A1 Brossard, Myriam
A1 Paterson, Andrew D.
A1 Espin-Garcia, Osvaldo
A1 Craiu, Radu V.
A1 Bull, Shelley B.
YR 2021
UL http://medrxiv.org/content/early/2021/05/11/2021.05.10.21256880.abstract
AB When quantitative longitudinal traits are risk factors for disease progression, endogenous, and/or subject to random errors, joint model specification of multiple time-to-event and multiple longitudinal traits can effectively identify direct and/or indirect genetic association of single nucleotide polymorphisms (SNPs) with time-to-event traits. Here, we present a joint model that integrates: i) a linear mixed model describing the trajectory of each longitudinal trait as a function of time, SNP effects and subject-specific random effects, and ii) a frailty Cox survival model that depends on SNPs, longitudinal trajectory effects, and a subject-specific frailty term accounting for unexplained dependency between time-to-event traits. Inference is based on a two-stage approach with bootstrap joint covariance estimation. We develop a hypothesis testing procedure to identify direct and/or indirect SNP association with each time-to-event trait. Motivated by complex genetic architecture of type 1 diabetes complications (T1DC) observed in the Diabetes Control and Complications Trial (DCCT), we show by realistic simulation study that joint modelling of two time-to-T1DC (retinopathy, nephropathy) and two longitudinal risk factors (HbA1c, systolic blood pressure) reduces bias and improves identification of direct and/or indirect SNP associations, compared to alternative methods ignoring measurement errors in intermediate risk factors. Through analysis of DCCT, we identify two SNPs with indirect associations with multiple time-to-T1DC traits and obtain similar conclusions using alternative formulations of time-dependent HbA1c effects on T1DC. In total, joint analysis of multiple longitudinal and multiple time-to-event traits provides insight into aetiology of complex traits.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis paper uses the data provided by the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group which is sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases contract (#N01-DK-6-2204), National Institute of Diabetes and Digestive and Kidney Diseases grants (#R01-DK-077510, #R01-DK077489, and #P60-DK20595). Funding for genotyping by Illumina HumanCoreExome was provided by JDRF (#17-2013-9). This project was supported by: CIHR Operating/Project Grants (#MOP-84287, #PJT159509), CANSSI postdoctoral fellowship (MB), CIHR STAGE fellowships (MB and OEG, #GET-101831). Computations were performed on the Niagara supercomputer at the SciNet HPC Consortium and Galen, the HPC facility at the Lunenfeld-Tanenbaum Research Institute (LTRI). SciNet is funded by: the Canada Foundation for Innovation under the auspices of Compute Canada; the Government of Ontario; Ontario Research Fund - Research Excellence; and the University of Toronto. The LTRI HPC facility was also supported by the Canada Foundation for Innovation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained for each of the 29 study centres across USA and Canada for the DCCT study. Ethical approval for the DCCT genetics study was obtained from the Hospital for Sick Children Research Ethics Board (Sickkids REB# 1000030543, Title: Genetics of diabetic complications and risk factors). We have current Research Ethics Board approval at Mount Sinai Hospital, Sinai Health System which includes the Lunenfeld-Tanenbaum Research Institute (MSH REB# 07-0208-E, Title: Genome-wide Association of Common Alleles with Long-term Diabetic Complications).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDCCT data are available to authorized users at https://repository.niddk.nih.gov/studies/edic/ and https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000086.v3.p1. Example R codes for DCCT-data-based simulation and analysis of the simulated data are provided on GitHub (https://github.com/brossardMyriam/Joint-model-for-multiple-trait-genetics). https://repository.niddk.nih.gov/studies/edic/ https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000086.v3.p1. https://github.com/brossardMyriam/Joint-model-for-multiple-trait-genetics DCCTDiabetes control and complications trialDRdiabetic retinopathyDNdiabetic nephropathyGWASgenome-wide association studyHbA1cHemoglobin A1cLDlinkage disequilibriumMAFminor allele frequencyPHproportional hazardsQT(s)quantitative trait(s)SBPsystolic blood pressureSNPsingle nucleotide polymorphismT1DCtype 1 diabetes complications